Sanofi SA at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript
Excellent. So good afternoon, everybody, and thank you for joining. I am Wimal Kapadia, the EU biopharma analyst here at Bernstein. It's my great pleasure to introduce Paul Hudson, CEO of Sanofi; and Jean-Baptiste de Chatillon, CFO of Sanofi.
So thank you both for joining today. I know it's been a very busy month for conferences within health care. So I really appreciate your time in your busy schedules.
So before we start, I'll just deliver housekeeping, I would like to remind investors that they are able to submit questions through the joint live Q&A link available to the left-hand side of your viewing screen. I will try and incorporate these questions as we move through the discussion. So please do participate, and it's nice to see several questions already posted online. So thank you very much for that. You can also provide feedback through the share and view investor sentiment link, which have immediate access to the poll results. If you do, the link will also appear at the conclusion of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |